Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Reed

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|August 26, 2016
Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell linesAbdulazeez Salawu, Malee Fernando, David Hughes, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and WalesRachid Rafia, Alan Brennan, Jason Madan, et al.
Gut|June 15, 2007
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancerCarolyn A Staton, Andrew S A Chetwood, Iain C Cameron, et al.
Patient Education and Counseling|May 1, 2012
Increasing readiness to decide and strengthening behavioral intentions: evaluating the impact of a web-based patient decision aid for breast cancer treatment options (BresDex: www.bresdex.com)Stephanie Sivell, Adrian Edwards, Antony S R Manstead, et al.
Medical Teacher|February 11, 2021
The influence of candidates' physical attributes on assessors' ratings in clinical practiceA H Sam, M D Reid, V Thakerar, et al.
Journal of Clinical Pathology|February 21, 2006
Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variablesS S Cross, R F Harrison, S P Balasubramanian, et al.
Breast Cancer Research : BCR|June 26, 2004
Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severityIman A F Azmy, Saba P Balasubramanian, Anthony G Wilson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast CancerGeoffrey R Holmes, Sue E Ward, Alan Brennan, et al.
The British Journal of Surgery|May 24, 2018
Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survivalS E Ward, P D Richards, J L Morgan, et al.
The British Journal of Surgery|July 1, 2020
Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancerS E Ward, G R Holmes, J L Morgan, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|August 26, 2016
Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell linesAbdulazeez Salawu, Malee Fernando, David Hughes, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Modeling the Cost-Effectiveness of Alternative Upper Age Limits for Breast Cancer Screening in England and WalesRachid Rafia, Alan Brennan, Jason Madan, et al.
Gut|June 15, 2007
The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancerCarolyn A Staton, Andrew S A Chetwood, Iain C Cameron, et al.
Patient Education and Counseling|May 1, 2012
Increasing readiness to decide and strengthening behavioral intentions: evaluating the impact of a web-based patient decision aid for breast cancer treatment options (BresDex: www.bresdex.com)Stephanie Sivell, Adrian Edwards, Antony S R Manstead, et al.
Medical Teacher|February 11, 2021
The influence of candidates' physical attributes on assessors' ratings in clinical practiceA H Sam, M D Reid, V Thakerar, et al.
Journal of Clinical Pathology|February 21, 2006
Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variablesS S Cross, R F Harrison, S P Balasubramanian, et al.
Breast Cancer Research : BCR|June 26, 2004
Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severityIman A F Azmy, Saba P Balasubramanian, Anthony G Wilson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast CancerGeoffrey R Holmes, Sue E Ward, Alan Brennan, et al.
The British Journal of Surgery|May 24, 2018
Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survivalS E Ward, P D Richards, J L Morgan, et al.
The British Journal of Surgery|July 1, 2020
Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancerS E Ward, G R Holmes, J L Morgan, et al.
Pageof 15